Incannex Healthcare (IXHL) Non-Current Assets (2022 - 2026)
Incannex Healthcare (IXHL) posted Non-Current Assets of $188000.0 for Q1 2026, down 42.68% sequentially from $328000.0 in Q4 2025, and down 66.9% YoY from $568000.0 in Q1 2025.
Incannex Healthcare (IXHL) Non-Current Assets (2022 - 2026) Analysis & Trends
Incannex Healthcare has reported Non-Current Assets for 5 years, with the latest figure at $188000.0 in Q1 2026.
- Quarterly Non-Current Assets fell 66.9% year-over-year to $188000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (down 50.04% YoY) and the FY2025 annual result came in at $485000.0, down 42.6% from the prior year.
- Non-Current Assets eased to $188000.0 in Q1 2026 per IXHL's latest filing, from $328000.0 in the prior quarter.
- Over five years, Non-Current Assets peaked at $53.1 million in Q4 2022 and troughed at $188000.0 in Q1 2026.
- A 5-year average of $5.0 million and a median of $694000.0 in 2023 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2023 and 2024: Non-Current Assets sank 98.07% in 2023, then grew 7.51% in 2024.
- Over 5 years, Non-Current Assets stood at $53.1 million in 2022, then tumbled by 98.07% to $1.0 million in 2023, then plunged by 41.38% to $602000.0 in 2024, then sank by 45.51% to $328000.0 in 2025, then plunged by 42.68% to $188000.0 in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $188000.0, $328000.0, and $425000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 2.96 Bn |
| 10 | Incannex Healthcare | 41.61 Mn | 41.61 Mn | - | 188,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 188,000.00 |
| Dec 31, 2025 | 328,000.00 |
| Sep 30, 2025 | 425,000.00 |
| Jun 30, 2025 | 485,000.00 |
| Mar 31, 2025 | 568,000.00 |
| Dec 31, 2024 | 602,000.00 |
| Sep 30, 2024 | 839,000.00 |
| Jun 30, 2024 | 845,000.00 |
| Mar 31, 2024 | 931,000.00 |
| Dec 31, 2023 | 1.03 Mn |
| Jun 30, 2023 | 786,000.00 |
| Dec 31, 2022 | 53.09 Mn |